Article ID Journal Published Year Pages File Type
10963100 Vaccine 2016 7 Pages PDF
Abstract
Hantavax™ showed a booster effect and immunogenicity lasting two years with a three-dose schedule. The neutralizing antibody response was quite poor with two primary doses, so an early booster vaccination at 2-6 months might be warranted to provide timely protection to high-risk subjects.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , ,